GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fortrea Holdings Inc (FRA:K67) » Definitions » 12-1 Month Momentum %

Fortrea Holdings (FRA:K67) 12-1 Month Momentum % : N/A% (As of May. 28, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Fortrea Holdings 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-28), Fortrea Holdings's 12-1 Month Momentum % is N/A%.

The industry rank for Fortrea Holdings's 12-1 Month Momentum % or its related term are showing as below:

FRA:K67's 12-1 Month Momentum % is not ranked *
in the Biotechnology industry.
Industry Median: -25.37
* Ranked among companies with meaningful 12-1 Month Momentum % only.

Competitive Comparison of Fortrea Holdings's 12-1 Month Momentum %

For the Biotechnology subindustry, Fortrea Holdings's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fortrea Holdings's 12-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fortrea Holdings's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Fortrea Holdings's 12-1 Month Momentum % falls into.



Fortrea Holdings  (FRA:K67) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fortrea Holdings  (FRA:K67) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Fortrea Holdings 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Fortrea Holdings's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Fortrea Holdings (FRA:K67) Business Description

Traded in Other Exchanges
Address
8 Moore Drive, Durham, NC, USA, 27709
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after LabCorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Fortrea Holdings (FRA:K67) Headlines

No Headlines